Literature DB >> 7020732

Comparison of piroxicam with indomethacin in ankylosing spondylitis: a double-blind crossover trial.

O A Sydnes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020732

Source DB:  PubMed          Journal:  Br J Clin Pract        ISSN: 0007-0947


× No keyword cloud information.
  7 in total

Review 1.  Pharmacological treatment of ankylosing spondylitis: a systematic review.

Authors:  Pauline Boulos; Maxime Dougados; Stuart M Macleod; Elke Hunsche
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 2.  Piroxicam. A reappraisal of its pharmacology and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

Review 3.  Current guidelines for the drug treatment of ankylosing spondylitis.

Authors:  E Toussirot; D Wendling
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

4.  Incidence of gastric ulcers by indomethacin and piroxicam in rats.

Authors:  C N Aguwa
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

5.  Ankylosing spondylitis. Current drug treatment.

Authors:  J T Gran; G Husby
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546

Review 6.  Piroxicam: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

Review 7.  Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).

Authors:  Féline P B Kroon; Lennart R A van der Burg; Sofia Ramiro; Robert B M Landewé; Rachelle Buchbinder; Louise Falzon; Désirée van der Heijde
Journal:  Cochrane Database Syst Rev       Date:  2015-07-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.